RECRUITING

PENG vs Femoral Block for Hip Fracture Analgesia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study aims to compare the Pericapsular Nerve Group (PENG) block with femoral block for hip fracture pain. Participants presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block will receive either a PENG or femoral block. The choice of block will be dictated by a randomized monthly schedule, and all participants presenting during each four-week period will receive the designated block. A sub-group analysis will be performed to determine any difference in efficacy in participants with intracapsular versus extracapsular fractures.

Official Title

PENG vs Femoral Block for Hip Fracture, A Pragmatic Cluster-Randomized Study

Quick Facts

Study Start:2025-07-10
Study Completion:2027-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07073209

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male or female ≥ 18 years of age.
  2. 2. ASA Classification 1-4
  3. 3. Documentation of a hip fracture diagnosis along with radiologic read indicating fracture location
  4. 4. Written, informed consent for analgesic peripheral block placement
  1. 1. Altered mental status to the extent that it limits ability to report pain score
  2. 2. Patient or health care proxy refusal of analgesic nerve block
  3. 3. Allergy to study medications or contraindication to peripheral nerve block
  4. 4. Chronic pain diagnosis on preoperative opioids

Contacts and Locations

Study Contact

Michele Steinkamp, BSN, RN
CONTACT
212-746-2953
mls9004@med.cornell.edu
Mark Abdelmassih, B.S.
CONTACT
212-746-2774
maa4068@med.cornell.edu

Principal Investigator

Tiffany Tedore, MD
PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University

Study Locations (Sites)

Weill Cornell Medicine
Manhattan, New York, 10065
United States

Collaborators and Investigators

Sponsor: Weill Medical College of Cornell University

  • Tiffany Tedore, MD, PRINCIPAL_INVESTIGATOR, Weill Medical College of Cornell University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-10
Study Completion Date2027-04

Study Record Updates

Study Start Date2025-07-10
Study Completion Date2027-04

Terms related to this study

Keywords Provided by Researchers

  • Pain
  • Anesthesia
  • Analgesia
  • Hip Fracture
  • Peripheral nerve block
  • Regional Anesthesia

Additional Relevant MeSH Terms

  • Hip Fractures